Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Solid Tumor Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07044336
What this trial is testing

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Who this might be right for
Endometrial CancerMalignant Solid Tumour
AstraZeneca 800
Early research (Phase 1)Ended earlyNCT04842630
What this trial is testing

Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Jiangsu HengRui Medicine Co., Ltd. 11
Early research (Phase 1)Study completedNCT06117371
What this trial is testing

Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation

Who this might be right for
Advanced or Metastatic Solid TumorKRAS G12C Mutation
BeBetter Med Inc 11
Very early researchEnded earlyNCT04712721
What this trial is testing

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Who this might be right for
Glioblastoma MultiformeBrain NeoplasmsGastroesophageal Adenocarcinoma+1 more
Novartis Pharmaceuticals 14
Early research (Phase 1)Ended earlyNCT00030693
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 42
Not applicableLooking for participantsNCT07727434
What this trial is testing

Stress and Anxiety Before Biopsy, After Biopsy Results, and During Treatment in Patients With Suspected Bone or Soft Tissue Cancer

Who this might be right for
Bone NeoplasmsSoft Tissue NeoplasmsAnxiety+1 more
Istanbul University 100
Not applicableLooking for participantsNCT05245136
What this trial is testing

Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.

Who this might be right for
Characteristics DiseaseMetastatic CancerSolid Tumor
University Hospital Augsburg 3,000
Early research (Phase 1)Looking for participantsNCT05232409
What this trial is testing

Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer

Who this might be right for
Cancer MetastaticMetastatic Solid Tumor
Valley Health System 72
Early research (Phase 1)Ended earlyNCT06488716
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumour
Genentech, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00012116
What this trial is testing

Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain

Who this might be right for
Metastatic Cancer
Jonsson Comprehensive Cancer Center 4
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Early research (Phase 1)Active Not RecruitingNCT04616534
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+19 more
National Cancer Institute (NCI) 14
Early research (Phase 1)Ended earlyNCT03948763
What this trial is testing

MRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)

Who this might be right for
NeoplasmsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms+1 more
Merck Sharp & Dohme LLC 70
Early research (Phase 1)Looking for participantsNCT07532902
What this trial is testing

BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

Who this might be right for
Diffuse Pleural MesotheliomaGastroesophageal CarcinomaUrothelial Carcinoma
Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT04474470
What this trial is testing

Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer

Who this might be right for
Solid Tumor, AdultSquamous Cell Carcinoma of Head and NeckColorectal Adenocarcinoma+3 more
TyrNovo Ltd. 52
Testing effectiveness (Phase 2)Study completedNCT02710253
What this trial is testing

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid Neoplasm
M.D. Anderson Cancer Center 214
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Early research (Phase 1)Study completedNCT02350673
What this trial is testing

Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 70
Early research (Phase 1)Looking for participantsNCT07027488
What this trial is testing

AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Melanoma and Normal or ImpairedAdvanced Melanoma
Yale University 50
Testing effectiveness (Phase 2)Study completedNCT04504942
What this trial is testing

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, Adult
CytoDyn, Inc. 16
Next Page